DNTH DIANTHUS THERAPEUTICS INC

Ownership history in VR Adviser, LLC  ·  10 quarters on record

This page tracks every 13F SEC filing in which VR Adviser, LLC reported a position in DIANTHUS THERAPEUTICS INC (DNTH). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
3.45% (2024 Q2)
Avg. % of fund
2.18%
First filed
2023 Q3
Last filed
2025 Q4
Quarters held
10
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 1,000,000 +39,197 +4.1% 2.04% $41.2M $41.21
2025 Q3 REDUCED 960,803 -39,197 -3.9% 2.13% $37.8M $39.35
2025 Q2 REDUCED 1,000,000 -744,373 -42.7% 1.40% $18.6M $18.63
2025 Q1 UNCHANGED 1,744,373 0% 2.69% $31.6M $18.14
6 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    DNTH price (monthly, adj. close)
← Back to VR Adviser, LLC Holdings